전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
the european commission granted a marketing authorisation valid throughout the european union for remicade to centocor b. v. on 13 august 1999.
august 1999 erteilte die europäische kommission dem unternehmen centocor b.v. eine genehmigung für das inverkehrbringen von remicade in der gesamten europäischen union.
infliximab was developed by junming le and jan vilcek at new york university school of medicine and developed by centocor, (now janssen biotech, inc.)remicade is marketed by janssen biotech, inc. (formerly centocor biotech, inc.) in the usa, mitsubishi tanabe pharma in japan, xian janssen in china, and schering-plough (now part of merck & co) elsewhere.
janssen biotech vertreibt remicade in amerika, mitsubishi tanabe in japan, xian janssen in china, sowie msd (ehemals von schering-plough resp.